Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Réglementation et droit · 02/10/20091 min de lecture
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Novel Use and Method of Rapamycin To Treat Toxic Shock
Traduction automatique locale · Langue originale de la source
Résumé
Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/231,348 entitled "Novel Use and Method of Rapamycin to Treat Toxic Shock," filed August 5, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Langue originale de la source: Federal Register — All DocumentsOuvrir le communiqué original →